Nov 11 (Reuters) – Kdventures AB: * CO'S PORTFOLIO COMPANY SVF VACCINES ENTERS RESEARCH COLLABORATION WITH OREXO ON POWDER-BASED LNP-MRNA VACCINES * STABLE POWDER-BASED FORMULATIONS COULD ENABLE
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
By Aishwarya Venugopal, David Shepardson and Courtney Rozen Nov 10 (Reuters) - Nvidia shed about…
Nov 11 (Reuters) - Qbim AB: * Q3 NET SALES AMOUNTED TO SEK 0.9 (0.7)…
New Delhi [India], November 11: As the Diwali festivities come to an end, many people…
By Jeslyn Lerh SINGAPORE, Nov 11 (Reuters) - Oil prices rose on Wednesday from the…
By Andrew Silver SHANGHAI, Nov 11 (Reuters) - Drugmakers in China are seizing on a…
(Recasts paragraph 1, adds details from paragraph 3 onwards) Nov 11 (Reuters) - Investments into…